{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Type 2 diabetes mellitus", "clinical trials", "compounds", "plants", "therapeutic effects"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "33884948", "DateCompleted": {"Year": "2021", "Month": "06", "Day": "16"}, "DateRevised": {"Year": "2022", "Month": "04", "Day": "23"}, "Article": {"ArticleDate": [{"Year": "2021", "Month": "04", "Day": "22"}], "Language": ["eng"], "ELocationID": ["10.1080/17512433.2021.1917380"], "Journal": {"ISSN": "1751-2441", "JournalIssue": {"Volume": "14", "Issue": "6", "PubDate": {"Year": "2021", "Month": "Jun"}}, "Title": "Expert review of clinical pharmacology", "ISOAbbreviation": "Expert Rev Clin Pharmacol"}, "ArticleTitle": "Clinical trials with plants in diabetes mellitus therapy: a systematic review.", "Pagination": {"StartPage": "735", "EndPage": "747", "MedlinePgn": "735-747"}, "Abstract": {"AbstractText": ["The chronic metabolic disorder diabetes mellitus is a fast-growing global problem with huge social, health, and economic consequences, having one of the highest morbidities and mortality rates. Prolonged use of many available medications can produce undesirable side effects. Thus, plants appear as an important source of bioactive resources for the discovery of new treatments for diabetes.", "In this sense, this systematic review focused on clinical trials involving plants of National List of Medicinal Plants of Interest to the Unified Health System (RENISUS) (or compounds) with antidiabetic properties. We analyzed indexed studies in PubMed following the reporting guidelines of PRISMA.", "Of the 51 clinical trials found, <i>Curcuma longa, Glycine max, Zingiber officinale, Punica granatum, Aloe vera, Momordica charantia</i> are the species with the greatest amount of clinical trials and the attenuation of insulin resistance, decreased fasting blood glucose and glycosylated hemoglobin levels are some of the main mechanisms by which these plants exert hypoglycemic effects. Thus, we speculate that the Clinical Pharmacology should explore the field of plant-based compounds that will keep concentrating the attention of researchers, and therefore, we gathered studies in advanced stages that highlight the role of plants in the diabetes therapy."]}, "AuthorList": [{"Identifier": ["0000-0001-5454-9099"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Programa De P\u00f3s-gradua\u00e7\u00e3o Em Biotecnologia, Universidade Do Vale Do Taquari - Univates, Lajeado, RS, Brasil."}], "LastName": "Marmitt", "ForeName": "Diorge Jonatas", "Initials": "DJ"}, {"Identifier": ["0000-0002-8638-1312"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Biotechnology Research Institute, Chinese Academy of Agricultural Sciences, Beijing, China."}], "LastName": "Shahrajabian", "ForeName": "Mohamad Hesam", "Initials": "MH"}, {"Identifier": ["0000-0002-3648-5033"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Programa De P\u00f3s-gradua\u00e7\u00e3o Em Biotecnologia, Universidade Do Vale Do Taquari - Univates, Lajeado, RS, Brasil."}], "LastName": "Goettert", "ForeName": "M\u00e1rcia In\u00eas", "Initials": "MI"}, {"Identifier": ["0000-0001-8573-0237"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Programa De P\u00f3s-gradua\u00e7\u00e3o Em Ambiente E Desenvolvimento/Programa De P\u00f3s-gradua\u00e7\u00e3o Em Sistemas Ambientais Sustent\u00e1veis, Universidade Do Vale Do Taquari - Univates, Lajeado, RS, Brasil."}], "LastName": "Rempel", "ForeName": "Claudete", "Initials": "C"}], "PublicationTypeList": ["Journal Article", "Systematic Review"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Expert Rev Clin Pharmacol", "NlmUniqueID": "101278296", "ISSNLinking": "1751-2433"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Blood Glucose"}, {"RegistryNumber": "0", "NameOfSubstance": "Hypoglycemic Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Preparations"}], "MeshHeadingList": [{"QualifierName": ["drug effects"], "DescriptorName": "Blood Glucose"}, {"QualifierName": ["drug therapy", "physiopathology"], "DescriptorName": "Diabetes Mellitus"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["isolation & purification", "pharmacology", "therapeutic use"], "DescriptorName": "Hypoglycemic Agents"}, {"QualifierName": [], "DescriptorName": "Insulin Resistance"}, {"QualifierName": ["methods"], "DescriptorName": "Phytotherapy"}, {"QualifierName": ["chemistry", "pharmacology", "therapeutic use"], "DescriptorName": "Plant Preparations"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants, Medicinal"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2021", "Month": "4", "Day": "23", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "6", "Day": "17", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "4", "Day": "22", "Hour": "8", "Minute": "39"}], "PublicationStatus": "ppublish", "ArticleIdList": ["33884948", "10.1080/17512433.2021.1917380"]}}], "PubmedBookArticle": []}